Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are scheduled to have coronary artery bypass graft (heart bypass) surgery
Who may not be able to join:
- People who are unable to sign a consent form agreeing to take part in the study
- People with significant kidney problems, where the kidneys are working at a reduced level (below a certain threshold), or who are already on dialysis
- People with moderate to severe heart weakness, where the heart's pumping ability is below 40%
- People who have previously been diagnosed with atrial fibrillation (an irregular heartbeat condition)
- People who are pregnant
- People who are also having heart valve surgery at the same time as their bypass surgery
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Leticia Carvalho, Instituto do Coração - HCFMUSP
Phone: + 5511 26615352
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Galectin-3 and post-operative atrial fibrillation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.